Predictive Value of Max’s Giant Associated Protein Mutation in Outcomes of Lung Adenocarcinoma Patients Treated With Immune Checkpoint Inhibitors

Treatment with immune checkpoint inhibitors (ICIs) has considerably improved prognosis in multiple cancers. However, regardless of PD-L1 expression and TMB, better predictive biomarkers are required to identify ICI-responsive patients. We analyzed a pan-cancer cohort as the discovery cohort to ident...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Yan, Wang, Chao, Liu, Lihui, Li, Sini, Zhang, Xue, Ma, Zixiao, Bai, Hua, Wang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558674/
https://www.ncbi.nlm.nih.gov/pubmed/34733843
http://dx.doi.org/10.3389/fcell.2021.728647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558674/
https://www.ncbi.nlm.nih.gov/pubmed/34733843
http://dx.doi.org/10.3389/fcell.2021.728647

Ejemplares similares